LUCAT1 and COVID-19: Taken together, our results suggest PIRAT and LUCAT1 to regulate largely discrete sets of genes in CD14+ monocytes during COVID-19, with LUCAT1 inhibiting STAT and promoting NF-κB target gene expression and PIRAT serving as a withdrawable inhibitor of PU.1-dependent programs.